100% Quality Guarantee
PhD-Level Technical Support
Key Features

GenieFluor 488 Anti-Mouse CD22 Antibody [Cy34.1] (AGEL0736)

SKU AGEL0736
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Mouse
Applications FC
$149 - $314

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

GenieFluor 488 Anti-Mouse CD22 Antibody [Cy34.1]

The Mouse CD22 Monoclonal Antibody (AF488 Conjugated) - CY34.1 (AGEL0736) is a specialized tool for researchers studying CD22, a cell surface protein known for its role in B cell signaling and development. This monoclonal antibody, conjugated with AF488 for fluorescence applications, is specifically designed for use in flow cytometry, immunofluorescence, and other fluorescence-based assays. By binding to CD22, this antibody allows for the visualization and analysis of CD22 expression in mouse samples, facilitating investigations into immune responses, B cell function, and antibody-mediated immunity.

CD22 is a crucial regulator of B cell activation and function, serving as a modulator of B cell receptor signaling and promoting immune tolerance. Studies involving CD22 have significant implications in understanding autoimmune diseases, B cell malignancies, and immune dysregulation. This monoclonal antibody provides researchers with a precise tool to investigate the expression and localization of CD22 in different cellular contexts, enabling a deeper exploration of the mechanisms underlying B cell responses and potential therapeutic targets in immunological disorders.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose